Clinical Trial Update: Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updating onvansertib in combination with low-dose cytarabine or decitabine for adult acute myeloid leukemia; study status completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Decitabine (Decitabine)
• Onvansertib (onvansertib)

Snippet

Sponsor: Cardiff Oncology | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-02-27